Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
Generic Drugs & Pharmacy News
IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.
The company is one of the first to launch a generic version of the discontinued Abilify Oral Solution used to treat depression, bipolar disorder and schizophrenia.
Levy will provide key insights on the changing healthcare industry to advance the board's mission of helping consumers make more informed healthcare decisions.
Aurobindo Pharma Limited announced Tuesday that it had received approval from the Food and Drug Administration for its over-the-counter cetirizine hydrochloride in 5- and 10-mg dosage strengths.
Mylan announced will continue to urge its shareholders to vote in favor of its proposed acquisition of Perrigo despite Institutional Shareholder Services’ recommendation against the deal in a recent report.
The research project will provide pharmacogenomics services in community pharmacies including collection of DNA samples, interpretation of patient results, counseling and collaboration with prescribers.
Dr. Reddy’s Laboratories has announced the launch and FDA approval of its pramipexole dihydrochloride extended release tablets.
Verde Technologies has announced a pilot program for its Deterra Drug Deactivation System that will see the company partner with the Delaware Prescription Action Committee (PDAC) and the Delaware Pharmacists Societyt to combat prescription drug abuse.
Testing on an edible on-dose authentication technology developed by TruTag Technologies is showing promising results for its use in combatting counterfeit drugs.